14
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TNU1478 |
5-Carboxy-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidine acetic acid
|
||
5-Carboxy-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidine acetic acid is a PNA-related Derivative; Heterocyclic Compound - Fused polyheterocycle. | |||
TNU1236 |
3,4-Dihydro-4-[[2-hydroxy-1-(hydroxymethyl)ethoxy] methyl]-3-oxo-2-pyrazinecarboxamide
|
||
3,4-Dihydro-4-[[2-hydroxy-1-(hydroxymethyl)ethoxy] methyl]-3-oxo-2-pyrazinecarboxamide is a Nucleoside Derivative - Acyclic nucleoside. | |||
TNU1474 |
(1,2-Dihydro-2-oxo-1,8-naphthyridin-3-yl)acetic acid
|
||
(1,2-Dihydro-2-oxo-1,8-naphthyridin-3-yl)acetic acid is a PNA-related Derivative; Heterocyclic Compound - Fused polyheterocycle. | |||
TNU1473 |
(1,2-Dihydro-2-oxo-1,8-naphthyridin-3-yl)acetic acid ethyl ester
|
||
(1,2-Dihydro-2-oxo-1,8-naphthyridin-3-yl)acetic acid ethyl ester is a PNA-related Derivative; Heterocyclic Compound - Fused polyheterocycle. | |||
TNU0440 |
7-Propargyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine
|
||
7-Propargyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine is a Nucleoside Derivative - Xylo-nucleoside, N-Methylated alkylated nucleoside; 8-Modified purine nucleoside. | |||
TNU0437 |
7-Ethyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine
|
||
7-Ethyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine is a Nucleoside Derivative - Xylo-nucleoside, N-Methylated alkylated nucleoside; 8-Modified purine nucleoside. | |||
TNU0441 |
7-(Butyn-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine
|
||
7-(Butyn-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine is a Nucleoside Derivative - Xylo-nucleoside, N-Methylated alkylated nucleoside; 8-Modified purine nucleoside. | |||
TNU0439 |
7-n-Butyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine
|
||
7-n-Butyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine is a Nucleoside Derivative - Xylo-nucleoside, N-Methylated alkylated nucleoside; 8-Modified purine nucleoside. | |||
TNU0386 |
1-Amino-7,8-dihydro-8-oxo-9-(b-D-xylofuranosyl) guanine
|
||
1-Amino-7,8-dihydro-8-oxo-9-(b-D-xylofuranosyl) guanine is a Nucleoside Derivative - Xylo-nucleoside; 8-Modified purine nucleoside; Amino nucleoside. | |||
TNU0322 |
6-Amino-2,5-dihydro-2-(b-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
|
||
6-Amino-2,5-dihydro-2-(b-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one is a Nucleoside Derivative - 7-deaza-8-aza purine nucleoside. | |||
TNU0438 |
7-n-Propyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine
|
||
7-n-Propyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine is a Nucleoside Derivative - Xylo-nucleoside, N-Methylated alkylated nucleoside; 8-Modified purine nucleoside. | |||
TNU1214 |
(3aR,5S,6S,6aR)-6-Benzy loxy-5-(benzyloxymethyl)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-6,6a-dihydro-3aH-furo[2,3-d][1,3]dioxole
|
||
(3aR,5S,6S,6aR)-6-Benzy loxy-5-(benzyloxymethyl)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-6,6a-dihydro-3aH-furo[2,3-d][1,3]dioxole is a Carbohydrate Derivative. | |||
TNU1213 |
(3aR,5R,6S,6aR)-5-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-5-(hydroxymethyl)-2,2-dimethyl-6,6a-dihydro-3aH-furo[2,3-d][1,3]-dioxol-6-ol
|
||
(3aR,5R,6S,6aR)-5-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-5-(hydroxymethyl)-2,2-dimethyl-6,6a-dihydro-3aH-furo[2,3-d][1,3]-dioxol-6-ol is a Carbohydrate Derivative. | |||
TNU1035 |
3,6-Dibromo-1,5-dihydro-1-(2,3,5-tri-O-benzoyl-b-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
|
||
3,6-Dibromo-1,5-dihydro-1-(2,3,5-tri-O-benzoyl-b-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one is a Nucleoside Derivative - 7-Deaza-8-aza-purine nucleoside; Halo-nucleoside; Scaffold and Template. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1899 |
Lycoramine
|
AChE | Neuroscience |
Lycoramine 是一种加兰他敏的二氢衍生物,从Lycoris radiate 中分离得到,是一种乙酰胆碱酯酶抑制剂。 |